Österreich » News & Media » Pressemitteilungen

Details

31.05.11

STALLERGENES STRENGTHENS ITS BOARD OF DIRECTORS

 

Stallergenes S.A, a European biopharmaceutical laboratory specialised in the treatment of severe respiratory allergies, strengthened its Board of Directors at its Combined General Meeting, held on 27 May 2011, with the appointment of three new members:

Gabriella Camboni, Jean-Luc Bélingard and Patrick Langlois.